Market Place
Sourcing Support
Impact of Baseline Dyskinesia on Safety and Efficacy of NOURIANZ®
26 May 2020 //
PR NEWSWIRE
Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline
06 Jan 2020 //
PR NEWSWIRE
Kyowa Kirin Announces NOURIANZ™ (Istradefylline) Now Available in the U.S.
14 Oct 2019 //
BUSINESSWIRE
HiFiBiO`s Kite-backed C round; Kyowa Kirin`s Parkinson`s nod; Relief for Sun
30 Aug 2019 //
FIERCE PHARMA
FDA approves new add-on drug to treat Parkinson`s disease
29 Aug 2019 //
BIOSPECTRUMASIA
Kyowa Kirin wins FDA nod for once-rejected Parkinson`s drug
28 Aug 2019 //
FIERCE PHARMA
FDA OK`s Kyowa Kirin`s istradefylline for Parkinson`s
27 Aug 2019 //
SEEKINGALPHA
Kyowa Kirin Announces FDA Acceptance Istradefylline (KW-6002) NDA resubmisstion
04 Apr 2019 //
BUSINESSWIRE
Kyowa advances Parkinson’s program despite being dropped by Lundbeck
20 Aug 2018 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.